#Concerns

NPPA greenlights 50% price hike for critical cancer drugs to avert supply crisis

The NPPA has approved a 50% price hike for cancer drugs Carboplatin and Cisplatin to resolve severe shortages, while also revising prices for key childhood vaccines.